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Summary 
Intraceilular pathways leading from membrane receptor engagement to apoptotic cell death are 
still poorly characterized. We investigated the intracellular signaling generated after cross-linking 
of CD95 (Fas/Apo-1 antigen), a broadly expressed ceil surface receptor whose engagement results 
in triggering of cellular apoptotic programs.  DX2, a new functional anti-CD95 monodonal 
antibody was produced by immunizing mice with human CD95-transfected L ceils. Crosslinkiug 
of CD95 with DX2 resulted in the activation of a sphingomydinase (SMase) in promydocytic 
U937 ceils, as well as in other human tumor ceil lines and in CD95-transfected  murine cells, 
as demonstrated by induction of in vivo sphingomydin (SM) hydrolysis  and generation of ceramide. 
Direct in vitro measurement of enzymatic activity within CD95-stimulated U937 cell extracts, 
using labded SM vesicles as substrates, showed strong SMase activity, which required pH 5.0 
for optimal substrate  hy&olysis. Finally, all CD95-sensitive  cell lines tested could be induced 
to undergo apoptosis after exposure to ceil-permeant C2-ceramide. These data indicate that CD95 
cross-linking  induces SM breakdown and ceramide production through an acidic SMase, thus 
providing the first information regarding early signal generation from CD95, and may be rdevant 
in defining the biochemical nature of intraceilular  messengers leading to apoptotic cell death. 
T 
he CD95 (Fas/Apo-1 antigen) is an *45-kD single trans- 
membrane receptor expressed on a variety of normal and 
neoplastic cells (1, 2). It has been suggested that CD95 may 
play a fundamental role in regulation of tissue development 
and homeostasis, since its molecular eross-linking results in 
apoptotic cell death (3, 4). In lymphoid cells, CD95 is pref- 
erentially induced on the ceLl surface after cellular activation 
(5) and its expression might be crucial to allow clonal selec- 
tion by cell ddetion in the thymus, as well as suicide of an- 
toreactive clones in the periphery. This is strongly suggested 
by the evidence that the autoimmune disease prone lpr mouse 
carries a mutation in the murine CD95 gene (6). Primary 
sequence analysis of the extraceUular portion of CD95 has 
revealed strong homologies with the extraceLlular  domain of 
receptors belonging to the TNF receptor family, which in- 
dudes TNF receptor types  1 and 2 (TNFR1/2),  the low 
affinity nerve growth factor receptor, and lymphocyte receptors 
such as CD27, CD30, CD40, and OX40 (1, 2). An integral 
membrane protein, with strong homology to TNF-ot and 
-~, has been recently identified as a Fas ligand (7). Moreover, 
a moderate degree of homology (26% identity in a stretch 
of 65 amino acids [aa]) between the intracdlular portion of 
the human CD95 and the 55-kD TNFR1, has been observed. 
Mutational analysis of this domain has revealed its involve- 
ment in the generation of the apoptotic signal from both 
CD95 and TNFR1 (8, 9). These data suggested that common 
effectors may transduce  the apoptotic signal from both re- 
ceptors. 
Whereas no information is available about the biochem- 
ical nature of the signals  generated  via  CD95,  signaling 
through TNFR1 has been extensivdy characterized. Its 221-aa 
intracellular portion has been shown to be functionally cou- 
pled with different phospholipases, including phospholipase 
A2 (PLA2)  1 (10), phosphatidylcholine-specific phospholipase 
C  (PC-PI,  C) (11), and sphingomydinase (SMase) (12, 14). 
A specific role for the SMase pathway, and in particular for 
ceramide, produced from sphingomydin (SM) hydrolysis, in 
1  Abbreviations used in this paper: PC-PLC, phosphatidylcholin~specific 
phospholipase C; PLA2, phospholipase A2; SM, sphingomydin; SMase, 
sphingomydinase. 
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gested by the demonstration that synthetic cell-permeant cer- 
amides  can directly promote  apoptosis  (15), by inducing 
double-stranded DNA fragmentation (16). We therefore in- 
vestigated whether SM hydrolysis and ceramide production 
could be induced by CD95.  Our data indicate that cross- 
linking of the CD95 receptor triggers SM breakdown in U937 
promydocytic  cells, as well as in other tumor cell lines, through 
an acidic SMase. 
Material, and Methods 
Generation ofAnti-CD95 mAbs.  Human Fas cDNA was gener- 
ated by P,T-PCR. (17) from the Jurkat cell  line and was subsequently 
subdoned into pBJ. Primers used to generate  a full-length  Fas cDNA 
were: sense, GGG CTC GAG ACA ACC ATG CTG GC~ ATC 
TGG (including an XhoI cloning site); anti-sense,  GGG GAT ATC 
TTC ACT CTA GAC CAA GCT TTG (containing an EcoRV 
cloning site). Murine L cells  were cotransfected  with 15 #g human 
Fas-pBJ plasmid using 100/~g lipofectin (GIBCO BRL, Gaithers- 
burg, MD) and CA18-resistant  cells  were selected, as described  pre- 
viously (18). Anti-CD95 hybridomas DX2 (IgG1) was generated 
by immunizing C3H/He mice with CD95 transfected L cells and 
fusing immune splenocytes with Sp2/0 myeloma cells. 
Cell Lines.  The human T cell lymphoma HUT78, human T 
cell leukemia  Jurkat, and human promydocytic leukemia  U937 cell 
lines were grown in R.PMI supplemented with 10% FCS, 1 mM 
glutamine, and antibiotics (complete medium). The routine lym- 
phocytic  leukemia  L1210 cell  line was transfected  with human CD95 
(Fas-pBJ plasmid) and G418 selected, as described previously (18). 
The resulting L1210-Fas cell line, stably expressing human CD95, 
was grown in complete medium. 
DNA  Labeling and Flow Cytometry Analysis.  Cells at  5  x 
10S/m1 in complete medium were incubated in 24-weU cell cul- 
ture plates (Costar Corp., Cambridge, M_A) coated with saturating 
amounts of DX2  antibody. In different experiments, cells were 
treated with 50 #M C2-ceramide (N-acetyl-n-sphingosine; Sigma 
Chemical Co., St. Louis, MO) or C2-dihydroceramide  (N-acetyl- 
n-dihydrosphingosine; Biomol, Plymouth Meeting, PA). After 
different times of incubation, cells were recovered and washed in 
PBS and processed for apoptotic cell detection (19). Briefly, the 
cell pellet was gently resuspended in 1 ml hypotonic fluorochrome 
solution (50/~g/ml propidium iodide in 0.1% sodium citrate plus 
0.1% Triton X-100, Sigma Chemical Co.) in 12  x 75 polystyrene 
tubes and kept overnight at 4~  in the dark until flow cytometry 
analysis. The propidium iodide fluorescence  emission of individual 
nuclei was filtered through a 585/42-nm band pass filter and mea- 
sured on a logarithmic  scale  by a FACScan  |  cytometer  (Becton  Dick- 
inson & Co., Mountain View, CA). Cell debris were exduded from 
analysis  by appropriately  gating on physical  parameters. The number 
of apoptotic cells was determined by evaluating the percentage of 
hypodiploid nuclei (20). 
SMase assay.  Cells were labeled for 48  h with [N-methyl- 
14C]choline (1 #Ci/ml, sp act 56.4 mCi/mmol) and then serum 
starved for 4 h in medium supplemented with 2% BSA (14). Ali- 
quots of 107 cells were suspended in 1 ml PBS and treated for the 
indicated times with control mAb or with DX2 mAb (1/~g/ml), 
cross-linked  by goat anti-mouse Ig (1 #g/ml), or with recombinant 
TNF-o~ (Genzyme Corp., Cambridge, MA) (100 ng/ml). Stimula- 
tion was stopped by immersion of samples in methanol/dry  ice 
(- 70~  for 10 s followed  by centrifugation at 4~  in a microfuge. 
Cell pellets were resuspended in ice-cold CH3OH/CHC13/H20 
(2.5:1.25:1). Phospholipids were extracted, dried under nitrogen, 
resuspended in 200/~1 chloroform, and applied to a Silica Gel TLC 
plate (Merck, Darmstadt, Germany), with an automatic applicator 
(Linomat IV; Camag, Muttenz, Switzerland). Samples  containing 
equal amounts of  radioactivity  were loaded. The amount of  labeled 
PC, which remained constant when labeled at equilibrium, was 
used as internal control to normalize for equal amounts of loaded 
material. Phospholipids were separated by TIC using a solvent 
system containing CHC13/CH~OH/CH3COOH/H20 (100:60: 
20:5). LysoPC, PC, and bovine brain SM (Sigma Chemical Co.) 
were used as standards and visualized in iodine vapor. The radio- 
active spots were visualized by autoradiography, scraped from the 
plate, and counted by liquid scintillation. SMase activity was ex- 
pressed as pmohs of SM hydrolyzed/106  cells. 
For in vitro SMase assay, the cells were treated with DX2 mAb 
(1/~g/ml) cross-linked by goat anti-mouse Ig (1 #g/ml) or with 
TNF-c~ (100 ng/ml) at 37~  for the indicated times, washed, and 
then resuspended in Tris buffer, pH 7.4, or sodium acetate buffer, 
pH 5.0, containing 10 mM PMSF, 100 mM bacitracin, I mM ben- 
zamidine, 1 mM aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 
and 5 mg/ml soybean  trypsin inhibitor (Sigma  Chemical  Co.). Cells 
were lysed by sonication with a cell sonifier (Vibracell, Sonic & 
Materials Inc., Danbury, CT). Protein concentrations were deter- 
mined using a protein assay  (Bio-Rad  Laboratories,  Richmond, CA). 
100 #g of the whole cell lysate was added to 250 #1 reaction buffer 
containing the substrate [N-methyl-l~C]SM (0.2 #Ci/ml, sp act, 
56.6 mCi/mmol), and 50 mM Tris or 50 mM sodium acetate (pH 
5.0), 150 mM NaC1, and 10 raM Ca  2+ (pH 7.4), with or without 
6 mM Mg  2+ . After incubation for 30 rain at 37~  the reaction 
was  stopped by the  addition of 250  #1 CHCI~/CH3OH/CH3 
COOH (4:2:1). Phospholipids  were extracted, TIE was performed 
as described above and [14C]SM hydrolysis  was quantitated by au- 
toradiography and liquid scintillation. SMase activation was ex- 
pressed as picomoles of SM hydrolyzed/10* cells. 
Ceramide Mass Measurement  (Diacylglycerot  Kinase Assay).  After 
stimulation, lipids were extracted and then incubated with Esche- 
richia coli diacylglycerol  kinase (21). Geramide phosphate was then 
isolated by TIE using CHCI3/CH3OH/CH3COOH (65/15/5, 
vol/vol/vol) as solvent. Authentic ceramide-l-phosphate  was iden- 
tified by autoradiography at Kf 0.25. Quantitative results for cera- 
mide production are expressed as pmohs of  ceramide-l-phosphate/ 
10' calls. 
Results 
DX2 Is a New Functional Anti-CD95  mAt~  A  series of 
mAbs  recognizing  CD95  was  produced  by immunizing 
C3H/He mice with murine L ceils transf~zted with the human 
Fas/Apo-1 gene (see Materials and Methods). DX2 mAb (IgG1) 
specifically reacts with murine L cells, murine L1210 leukemia 
cells, and murine P815 mastocytoma cells transfected with 
human Fas cDNA, but does not react with the untransfected 
parental cells, by FACS  |  analysis (data not shown). The ability 
of the DX2 mAb to deliver an apoptotic signal was inves- 
tigated on L1210 cells stably transfected with human CD95 
(L1210-Fas). Apoptosis induction was evaluated as decrease 
of cellular DNA content by propidium staining and FACS  | 
analysis (19). Fig.  1 C  shows that >70% of L1210-Fas cells 
were undergoing apoptosis within 12 h from the stimula- 
tion with DX2 mAb. Apoptotic cells within untransfected 
L1210 treated with DX2 mAb or within L1210-Fas cells treated 
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Figure  t.  Apoptosis induction  by DX2 mAb. L1210 cells incubated for 
12 h on DX2-coated phtes (A), L1210-Fas  cells incubated for 12 h on Len3a 
(anti-CD4)-coated (B), or DX2-coated (C) plates, were processed for DNA 
content analysis  by propidium iodide staining. Nuclei were analyzed with 
a FAScan  |  cytofluorimeter and data plotted on log histograms as red fluores- 
cence intensity  (x ax/s) vs. relative cell number ~ ax/s). Hypodiploid nuclei 
(between markers), are 1, 2, and 73% in A, B, and C, respectively. (D) 
Kinetic  analysis  of apoptosis induction  in L1210-Pas  cells after CD95 cross- 
linking  by DX2 mAb. Cells treated as above described were collected at 
different time points and processed for DNA content analysis  by propidium 
iodide staining. Data shown are from one representative out of several ex- 
periments  performed. 
different time points and analyzed by TIC. Fig. 2 A  shows 
that cross-linking of CD95 in U937 cells resulted in significant 
hydrolysis of SM, which reached maximal levels by 5 rain, 
and was completed within 30 rain. Comparable peak levels 
of SM hydrolysis were observed by treating U937 cells for 
5 rain with 100 ng/ml TNF-o~, used as positive control (Fig. 
2 B). Significant levels of SM hydrolysis were also observed 
5 min after CD95 cross-linking in HUT78 and Jurkat cell 
lines (Fig. 2 B), indicating that CD95-induced SM turnover 
was not restricted to U937 cells. Finally, remarkable SM hy- 
drolysis was induced by anti-CD95 mAb DX2 in L1210-Fas 
calls (Fig. 2 B), further indicating that expression of CD95 
is sufficient to enable functional coupling with a SMase. 
SM hydrolysis was paralleled by generation of ceramide, 
as detected by TLC analysis of phospholipids extracted from 
DX2-stimulated U937 cells and subjected to diacylglycerol 
kinase assay (Fig. 3 A). Ceramide accumulation peaked at 
10 rain after CD95 cross-linking (Fig. 3 B). Sphingosine for- 
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with control mAb for 12 h were <2%  (Fig.  1, A  and B). 
Kinetic analysis showed that a significant fraction of cells was 
undergoing apoptosis within 6 h from CD95 stimulation, 
and that almost all nuclei were hypodiploid by 24 h (Fig. 
1 D). Very similar results were obtained with P815 cells trans- 
fected with human CD95 (data not shown). These data in- 
dicated that the DX2 mAb recognized a functional epitope 
of the CD95 antigen. 
SM Breakdown is Induced by CD95 Cross-linking.  Cross- 
linking of TNFR-1 by TNF-cr in promyelocytic U937 calls 
results in SM hydrolysis and ceramide production (14). The 
activation of SM turnover has been suggested to play an im- 
portant role in initiating the biochemical pathway leading 
to  active  cell  death,  since  synthetic ceramide analog C2- 
ceramide has been shown to be directly responsible for apop- 
tosis induction in U937 cells (15). As U937 cells express CD95 
and are susceptible to CD95-mediated apoptosis induction 
(3), we investigated whether cross-linking of CD95 could 
induce SM breakdown in U937 cells. U937 cells were labeled 
with [/N/'-methyl-14C] choline for 48 h and stimulated with 
1 #g/ml anti-CD95 mAb DX2, together with 1/~g/ml GuM 
to maximize cross-linking, since molecular cross-linking has 
been shown to be critical for CD95-mediated apoptosis in- 
duction (22). Cellular phospholipids were then extracted at 
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Figure 2.  SM hydrolysis  by anti-CD95 mAb. (.4) U937 cells were 14C- 
choline  labded and stimulated for different times with control anti-CD45 
mAb (open circles) or anti-CD95 mAb (closed triangles). Phospholipids were 
then extracted, separated  by TIC, and visualized by autoradiography. Rele- 
vant spots were scraped from the plate and counted by liquid scintillation. 
Data are expressed as pmoles of SM hydrolyzed in stimulated samples (closed 
triangles) and unstimulated ones (open circles). Mean values and standard 
deviations at each time point, from four different experiments are shown. 
(B) Different cell lines were ~4C-choline  labeled and stimulated for 5 rain 
with anti-CD95 mAb or TNF-,v. Phospholipids were then extracted, sepa- 
rated by TIC, and visualized by autoradiography.  Relevant spots were 
scraped from the phte and counted by liquid scintillation. Data are ex- 
pressed as pmoles of SM hydrolyzed in stimulated samples (shaded bars) 
and unstimuhted ones (hatched bars). 
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Figure 4.  pH  dependency  of 
CD95-dependent  SMase. U937 cells 
were  stimulated  with  anti-CD95 
mAb or TNF-o~, and cell lysates  were 
then adjusted to the indicated pH. 
After reaction of celt lysates with la- 
beled SM vesicles  in the proper buffer, 
phospholipids were extracted,  sepa- 
rated by TIC, and visualized by au- 
toradiography.  Relevant spots  were 
scraped from the plate and counted 
by liquid sdntiUation.  Data are ex- 
pressed as pmoles of SM hydrolyzed 
in samples  from U937 cells  stimulated 
with TNF (open  columns), anti-CD95 
mAbs (shaded columns),  or left  un- 
treated  (hatched columns). 
Figure 3.  Ceramide  accumulation  after anti-CD95 stimulation. (.,t) 
U937 cells were stimulated with anti-CD95 mAb for different times, and 
lipids were then extracted and subjected  to diacylglycerol  kinase assay. Lipids 
were separated by TLC and radioactive spots visualized by autoradiog- 
raphy. (st) Ceramide authentic standard, (or) chromatographic origin. (B) 
Quantitative  results for ceramide-l-phosphate accumulation, expressed as 
picomoles/106 cells. Two different experiments gave similar results. 
mation was observed, (band migrating at lower Kf in TLC), 
possibly due to rapid in vitro ceramide catabolism by cerami- 
dases. The above results suggested that cross-linking of CD95 
could transiently activate a cellular SMase to hydrolyse SM 
and generate ceramide. 
CD95 Cross-linking Activates an Acidic SMase.  SMases  rep- 
resent a family of widely distributed type-C phospholipases. 
Although all SMases hydrolyse SM to generate ceramide and 
phosphorylcholine, ~hey are heterogeneous in activation re- 
quirements and cdlular localization (23).  Neutral SMases 
operate preferentially outside or at the plasma membrane, with 
a pH optimum of 7.4,  and require Mg  2+, whereas acidic 
SMase are localized intracellularly and in lysosomes,  have a 
pH optimum of 5.0, are Mg2+-independent and require 1,2- 
diacylglycerol  for activation (24,  25).  It was of interest to 
characterize  the SMase species involved in CD95 signaling. 
CD95-activated SMase activity was therefore evaluated in vitro 
on purified substrate,  under different pH conditions. U937 
cells were stimulated for 5 rain with 1/~g/ml anti-CD95 mAb 
DX2 and 1 #g/m1 GaM, and cell extracts were then incubated 
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Figure 5.  Sensitivity to ceramide. U937, HUT78, Jurkat,  and L1210- 
Fas cell lines were treated with 50/~M C2-ceramide  (closed  circles) or 50/~M 
C2-dihydroceramide  (open circles). At different time points, cells were ana- 
lyzed for apoptosis induction by propidium iodide staining. Nuclei were 
analyzed with a FACScan  |  cytofluorimeter. Percent hypodiploid nuclei in 
each cell line is plotted  versus time elapsed. 
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As shown in Fig. 4, optimal SMase activity was detected at 
pH 5.0, whereas at pH 7.4 enzymatic activity was minimal. 
Addition of 6 mM Mg  2+ to the reaction buffers did not re- 
sult in any change in CD95-triggered SMase activity (data 
not shown). Cell extracts from TNF-ot-stimulated U937 cells, 
used as positive control, also contained acidic SMase activity, 
as reported (14). These data indicated that CD95 cross-linking 
was activating an acidic  SMase. 
Ceramide Mediates Apoptosis in CD95-sensitive Cell Lines.  To 
further investigate the role of ceramide in CD95-induced cell 
death, we tested whether cell lines which were shown to 
generate ceramide upon CD95 cross-linking, were in fact in- 
duced to undergo apoptosis by exogenous ceramide. U937 
cells, as already described (15), but also Jurkat, HUT78, and 
CD95-transfected L1210 cells, rapidly underwent massive apop- 
tosis upon exposure to cell-permeant synthetic C2-ceramide. 
By  contrast,  cell-permeant  structural  analog  C2-dihydro- 
ceramide was totally ineffective (Fig. 5). These data strongly 
suggest that CD95-mediated ceramide generation is respon- 
sible for apoptosis induction in CD95-sensitive cells. 
Concluding Remarks.  Different  cytokine receptors,  in- 
cluding those for TNF-ot, IFN-3,, and IL-lfl, have been shown 
to trigger SM turnover, as part of their signaling capabilities, 
upon ligand binding (12,  13, 26).  SM hydrolysis with cera- 
mide production is emerging as a major receptor-operated 
cell activation pathway (27),  highly conserved along evolu- 
tion (28)  and possibly implicated in multiple gene regula- 
tory events, leading to as diverse outcomes as growth inhibi- 
tion and cell differentiation (29, 30) or cellular proliferation 
(31).  Ceramides, in fact, can activate at least two distinct 
Ser/Thr kinases (32), one of which was identified as the 42-kD 
mitogen-activated protein kinase (33), and a cytosolic Ser/Thr 
protein phosphatase 2A (termed ceramide-activated protein 
phosphatase or CAPP) (34).  The effects of C2-ceramide on 
apoptosis induction of U937 cells (15), and the identification 
of a "death domain" common to CD95 and TNFR-1 (8, 9), 
suggest the possibility that the SM pathway could mediate 
apoptotic signaling through CD95. 
CD95-generated early signaling has remained elusive so 
far, as no early enzymatic activity or intracellular [Ca2+]i ele- 
vations, after CD95 cross-linking, have been reported. The 
data presented here provide the first attempt to characterize 
the signaling pathway originated at the CD95 receptor. They 
demonstrate that cross-linking of CD95 activates an acidic 
SMase in U937 cells and suggested that released ceramide 
could be involved in mediating CD95-dependent apoptosis. 
Although ceramides are likely candidates as mediators of 
CD95-dependent apoptosis, and CD95 triggers SM break- 
down in all CD95 + call lines tested, a marked heterogeneity 
in susceptibility to CD95-mediated apoptosis induction among 
the different cell lines or among fleshly isolated cells has been 
observed (5 and our unpublished data). This suggests a com- 
plex and possibly call-specific regulation of the CD95-depen- 
dent SMase pathway, which will require further investigation. 
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